ABSTRACT
INTRODUCTION
The biological function of proteins is often investigated by transient overexpression of a particular gene product in cultured cells. Transient transfection offers a quick and simple assay to evaluate the potential activity of proteins, such as transcription factors and cellcycle regulatory proteins. However, due to the variable proportion of cells taking up the DNA and to variations in culture conditions, transient transfection is sometimes difficult to repeat, and frequently cannot provide enough transfected cells for biochemical analysis. In our experience, successful purification of a multisubunit protein complex is unlikely to be achieved by simply overexpressing a single protein subunit by transient transfection. This problem is further complicated by the stoichiometric ratio among all other subunits in a multiprotein complex. To overcome these difficulties, we and others have used retrovirus-mediated gene transfer techniques to establish stable cell lines that constitutively express epitope-tagged proteins for purification of multiprotein complexes, such as the basal transcription factor TFIID (1, 13) . The introduced epitope tag also provides a convenient site for affinity purification by monoclonal antibodyconjugated beads. This purification strategy has been successfully applied to many other protein complexes (1; S.-Y. Wu and C.-M. Chiang, unpublished data). Nevertheless, attempts to establish stable cell lines that express other transcription factors by a retroviral approach have failed, partly due to the potential cytotoxicity of these proteins.
Conditional expression of a foreign gene product is invaluable in assessing the biological function of a protein during specific stages of development, cellular growth and division cycles. Conversely, inhibition of endogenous protein expression can also reveal the effect(s) of the protein on cellular activities. However, it has been difficult to produce effective regulated expression for studies in vertebrate cells. Recently, a tetracycline-regulated expression system (9) has been successfully applied to mammalian cells for controlled expression of an ectopic gene product. This inducible system relies on a bacterial tetracycline repressor (TcR) that binds to DNA recognition sites only in the absence of tetracycline. In the presence of the antibiotic, ligand-induced conformational change of the TcR DNA-binding domain prevents it from binding to the cognate DNA sequence. This "on" and "off" regulation offers a precise control for protein expression in mammalian cells because tetracycline does not change the overall metabolism in mammalian cells, as do other inducers such as heat shock, heavy metals and hormones (8) . This approach has also been used to create transgenic mice for conditional expression of specific gene products (7) . For this system to work in mammalian cells, the DNAbinding domain of TcR was linked to the acidic activation domain of VP16. This tetracycline-dependent transactivator (tTA), i.e., TcR-VP16 fusion protein, acts as a transcriptional activator when it binds to specific DNA sites located upstream of eukaryotic promoters used to drive the expression of inserted genes. A HeLa-derived cell line (HtTA-1) that constitutively expresses tTA was established for induced expression of foreign gene products (9) .
Overexpression of a crucial tran -scription factor in cells may disturb cellular metabolism, resulting in cell death. This might be due to cytotoxicity exerted by unregulated expression of ectopic gene products. Since we could not establish stable cell lines expressing several epitope-tagged transcription factors using retrovirus-mediated gene transfer, we have resorted to the tetracycline-regulated expression system that can turn gene expression "on" or "off" depending on the availability of tetracycline (9) . In this report, we describe an adaptation of the tetracyclineregulated expression system, in combination with FLAG epitope-tagging (2), to establish stable cell lines that conditionally express potentially toxic proteins which can be easily purified for biochemical analysis.
MATERIALS AND METHODS

Construction of TetracyclineRegulated Plasmids Expressing FLAG-Tagged Basal Transcription Factors
Two oligonucleotides, 5 ′ CATGGA-CTACAAAGACGATGACGATAAAC -A-3 ′ and 5 ′ -TATGTTTATCGTCATCG -TCTTTGTAGTC -3 ′ , were individually synthesized and annealed to form a double-stranded oligonucleotide. This double-stranded oligonucleotide containing the FLAG epitope sequence with flanking Nco I and Nde I sites was used to replace the original FLAG sequence that also contains a kinase phosphorylation site in both pFLAG(S)-7 (2) and pFLAG(AS)-7 (1) to create, respectively, pFLAG o (S)-7 and pFLAG o (AS)-7 ( Figure 1A ). All these FLAGcontaining cloning plasmids have a Kozak consensus sequence (10) inserted between the Bgl II and Nco I sites to facilitate expression in mammalian cells. The Eco RI-BamHI fragment of pFLAG o (S)-7 was then cloned into pUHD10-3 (11) at the corresponding sites to generate pTetCMV-F o (S) (Figure 1B) . Similarly, the Cla I-Xba I fragment of pFLAG o (AS)-7 was cloned into pUHD10-3 between the Eco RI and Xba I sites after Klenow filling-in at the Cla I and Eco RI sites (which regenerates the Eco RI site) to make pTetCMV-F o (AS) ( Figure 1B (6) as N-terminal Nde I (introduced at the first initiation codon)-Eco RV and C-terminal Eco RVBamHI fragments, and cloned into pFLAG(S)-7 and pF:TBP-11d (2), after removing the TBP insert, between the Nde I and BamHI sites to generate pF:62(H)-7 and pF:62(H)-11d, respectively. The entire FLAG-tagged p62 cDNA was then cleaved from pF: 62(H)-7 by BamHI and partial Eco RI digestion, and cloned into pUHD10-3 between the Eco RI and BamHI sites to create pTetCMV-F:62(H) for conditional expression of the p62 subunit of human TFIIH in mammalian cells.
Establishment of TetracyclineRegulated Clonal Human Cell Lines
To establish stable cell lines that conditionally express epitope-tagged TBP, TAF II 55 and p62, we cotransfected 10 µ g of each Pvu I-linearized pTet -CMV-F o :hTBP, pTetCMV-F o :hTAF II 55, pTetCMV-F o :hTAF II 55/A + or pTet -CMV-F:62(H) with 50 µ g of sheared calf thymus DNA and with 0.5 µ g of Sac I-linearized pREP4 (Invitrogen, San Diego, CA, USA) that contains the hygromycin-resistant gene into HtTA-1 (9), a HeLa-derived cell line that constitutively expresses a tetracycline-controlled tet R-VP16 transactivator (tTA). Transfection was performed by electroporation (Bio-Rad, Hercules, CA, USA) at 960 µ F and 200 V as previously described (4) . After electroporation, the cells were left at room temperature for 10 min and then transferred to a 15-mL centrifuge tube containing 10 mL growth medium (Dulbecco's modified Eagle medium [DMEM] plus 10% fetal bovine serum [FBS] ). Following spinning at 1000 rpm using a Sorvall ® RC-3B Plus centrifuge with an H6000A rotor (Du Pont, Wilmington, DE, USA) for 5 min to remove debris, the cells were plated onto five 100-mm plates and left in a 37°C, 5% CO 2 incubator for two days before initiating drug selection (400 µ g/mL of G418, 200 µ g/mL of hygromycin B and 2 µ g/mL of tetracycline). G418 sulfate (Geneticin ® ; Life Technologies, Gaithersburg, MD, USA) and tetracycline (Sigma Chemical, St. Louis, MO, USA) were dissolved in water as 1 mg/mL stock solution, whereas hygromycin B (Boehringer Mannheim, Indianapolis, IN, USA) was purchased as 20 mg/mL solution. These antibiotics were added to the growth medium before use. The medium was changed every 3 or 4 days and selection was continued for approximately 3 weeks until drug-resistant colonies were clearly visible. Twelve colonies were then picked up and expanded into cell lines. To identify positive clones responding to tetracycline, cells were plated onto two 60-mm dishes in selection medium, with or without tetracycline, for 48 to 72 h. Subconfluent cells were then lysed in 250 µ L of sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) sample buffer and used for Western blotting.
Western Blotting
Proteins were transferred from either 10% (for TBP and TAF II 55) or 8% (for p62) SDS-PAGE gels to nitrocellulose filters at 0.8 mÅ/cm 2 for an hour by a NovaBlot ™semi-dry blotting apparatus (Pharmacia Biotech, Piscataway, NJ, USA). The anti-FLAG M2 monoclonal antibody (Scientific Imaging Systems, Eastman Kodak, New Haven, CT, USA), anti-TAF II 55 (3) and anti-p62 polyclonal antibodies (obtained from H. Xiao, Rockefeller University, New York) were diluted at 1:1000 fold in 1 × TBST (10 mM Tris-
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HCl, pH 8.0, 150 mM NaCl, 0.05% Tween ® 20) containing 5% nonfat milk. These primary antibodies were incubated, individually, with filters at room temperature for an hour. After brief rinsing with distilled water (two times) and extensive washing with 1 × TBST (four times, 5 min each wash), the filters were incubated with 2000-fold dilutions of horseradish peroxidase-conjugated secondary antibodies (Amersham, Arlington Heights, IL, USA) in 1 ×TBST plus 5% non-fat milk at room temperature for 20 min. The filters were extensively washed again as described above. Signals were then detected by EC L ™ (Amersham) according to the manufacturer's instructions.
Cell Maintenance
HtTA-1 cells were grown in DMEM supplemented with 10% FBS either with or without G418 (0.4 mg/mL of active components). All clonal human cell lines expressing FLAG-tagged proteins were usually maintained in DMEM plus 10% FBS with 1 µ g/mL of tetracycline, unless otherwise specified in individual experiments.
Protein Purification
The p62 bacterial expression plasmid, pF:62(H)-11d, was introduced into a bacteria strain BL21(DE3)pLysS (12) . Purification of bacterially expressed FLAG-tagged p62 (f:62) was conducted as previously described for FLAG-tagged TBP, without rifampicin (2) . Nuclear extracts of the 3-10 human cell, a HeLa-derived cell line that constitutively expresses FLAG-tagged human TBP (1), were prepared according to the published procedure (5). The 0.85 M KCl fraction of the phosphocellulose P11 (Whatman, Hillsboro, OR, USA) ion-exchanger column was isolated from nuclear extracts of 55-9, a HeLa-derived cell line that constitutively expresses human FLAG-tagged TAF II 55 (3).
RESULTS
Characterization of TetracyclineRegulated Clonal Human Cell Lines
To establish clonal human cell lines that conditionally express FLAGtagged basal transcription factors, including human TBP, the TAF II 55 subunit of human TFIID and the p62 subunit of human TFIIH, we have modified a pre-existing tetracycline expression plasmid to include a FLAGepitope tag (Figure 1 ), thereby facilitating later purification of these proteins for biochemical analysis. This simpler version of the FLAG-epitope tag (F o ) does not contain a heart muscle kinase phosphorylation site initially introduced in our FLAG expression vectors (1,2). To enhance the transfection efficiency, we employed electroporation to deliver cloned genes into HtTA-1 cells that express a tetracycline-regulated transactivator (9 
Preselection of Clonal Cell Lines with G418 Enhances TetracyclineRegulated Gene Expression
To compare the levels of protein expression achieved between the tetracycline-regulated expression system and the retroviral system, we conducted Western analysis using cell lysates harvested from 3-10, 55-9 and F o :55-6 cells. Since the amount of the tetracycline-regulated transactivator (tTA) in 8) , therefore, served as controls for protein transfer on either side of the gel.
Modulation of the Protein Expression by the Amount of Tetracycline
The tetracycline-regulated expression system also offers a unique method to modulate the level of protein expression (9) . Depending on the amount of tetracycline included in the growth medium, the levels of f o :TBP and f o :TAF II 55 could be varied over three orders of magnitude (Figure 4) . Induced expression of FLAG-tagged proteins was clearly detected by Western blotting when the concentrations of tetracycline dropped below 1 ng/mL. The tagged proteins, if present, were barely detected when tetracycline was higher than 10 ng/mL. The dosage-responsive effects were very similar among clonal cell lines that expressed different proteins (Figure 4) , suggesting that the induced protein expression is mainly determined by the DNAbinding property of tTA, regardless of the nature of the expressed protein.
Measurement of the In Vivo Protein Half-Life
By controlling the availability of tetracycline, we can turn "on" and "off" a particular gene expression at a specific time and location. To prevent a potential cytotoxic effect resulting from the overexpression of tTA and tetracycline-regulated gene products, we usually maintain clonal cells in the presence of only 1 µ g/mL tetracycline. Once tetracycline is removed from the growth medium, expression of the tetracycline-regulated proteins is induced and reaches the maximum level in approximately 24 hours for TAF II 55 and 48 hours for TBP, and remains constant for at least 5 days (data not shown). Interestingly, when tetracycline was added back to the cells, the induced proteins started to decay (Figure 5A) . The levels were reduced by approximately one-half within 20 hours for TBP ( Figure 5B ) and within 6 hours for TAF II 55 ( Figure 5C ). In the case of TAF II 55, the reduction of exogenous FLAG-tagged TAF II 55 was clearly compensated for by the increase in endogenous TAF II 55 ( Figure 5C ), indicating a tightly regulated control of the overall protein level on this critical transcription factor that mediates activator response. Tetracycline-regulated expression of FLAG-tagged TBP and FLAG-tagged TAF II 55 was specific, as no change in the protein levels of other TFIID subunits was observed in the presence or absence of tetracycline (data not shown). This provided us with an estimation of the in vivo protein half-lives inferred directly from the protein level, not relying on the 722BioTechniques
Vol. 21, No. 4 (1996) Figure 3 . G418 enhances tetracycline-regulated gene expression. Western blotting was performed as described in Materials and Methods with the anti-TAF II 55 antiserum No. 3095 (3), which also contains antibodies against the FLAG-epitope tag. F o :55-6 cells in a 100-mm plate were pre-selected in G418 (400 µ g/mL), in the presence of tetracycline (1 µ g/mL), for two weeks before cells in a subconfluent (ca. 80%-90% confluent) 100-mm plate were split to twenty-four 60-mm plates for protein induction. At that time, G418 was no longer included in the medium. Cell lysates were collected after 72 hours and used for Western blotting. amplified signals through enzymatic activities when LacZ and luciferase reporter genes were used.
DISCUSSION
The tetracycline-regulated expression system is an effective approach for conditional expression of foreign gene products in mammalian cells. This system allows the expression of potentially toxic proteins in a controlled manner, depending on the amount of tetracycline in the growth medium. Introduction of the FLAG-epitope tag into the tetracycline-regulated plasmids (Figure 1 ) further extends the potential of the system for biochemical analysis. The introduced FLAG tag offers several advantages. 1) It serves as a marker for tracking proteins before anti-protein antibodies become available. 2) It is synthetic. Very few, if any, cross-reacting species are detected in bacterial, yeast, insect and mammalian cells. 3) It is very hydrophilic and tends to help proteins solubilize in aqueous solution. 4) Purification of FLAG-tagged proteins can be easily achieved by affinity purification and peptide elution methods (2) . Proteins with the FLAG-epitope tag will be retained on the anti-FLAG M2 monoclonal antibody-conjugated agarose beads. After extensive washing off the unbound proteins, the FLAG-tagged proteins can be easily isolated by incubation with the synthetic FLAG peptide, which competes with the antibodybinding sites on the M2-agarose beads, thereby allowing recovery of FLAGtagged proteins (and associated polypeptides) under mild conditions in a form ready for functional assays. 5) A heart muscle kinase (HMK) phosphorylation site linked to the FLAG sequence in our original FLAG expression vectors (2) offers a unique way to label proteins with radioisotope 32 P after purification. The labeled proteins can be used for interaction studies, expression library screening, protein tracking and so forth. However, the HMK site may also complicate the issues for cell cycle studies, such as monitoring protein phosphorylation changes through cell cycle progression. Therefore, a simpler version of the FLAG tag sequence was used in our current studies for the inducible expression of TBP and TAF II 55. 
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Our previous attempts to establish stable cell lines that constitutively express some critical transcription factors, such as the p62 subunit of human TFIIH, were not successful. This is presumably due to the cytotoxicity of these transcription factors on cellular metabolism when overexpressed. Using the combined tetracycline-regulated and FLAG-epitope tagging methods, we are able to conditionally express the FLAG-tagged p62 (f:62) subunit of human TFIIH in HeLa cells (Figure 2) . The establishment of the f:62-expressing cell line F:62(H)-8 ( Figure 2 ) by the tetracycline-regulated expression system is a major breakthrough in studies of transcriptional regulation, as it is now possible to purify sufficient amounts of homogeneous human TFIIH for biochemical analysis.
Expression of tetracycline-regulated proteins was greatly enhanced by preselection of clonal cells with G418 ( Figure 3 ). Since high levels of tTA expression may be toxic to cells, the amount of transactivators present in HtTA-1 and its derived cell lines may become limiting through multiple passages. This reduction presumably protects cells from cytotoxicity exerted by overexpression of tTA. Interestingly, we were able to further enhance the expression of the tagged proteins at least another tenfold by preselection with G418, which was employed as a selection marker initially to cotransfect with a tTA expression plasmid for the establishment of HtTA-1 cells. Since very few, if any, cells died during the twoweek G418 selection, we tend to believe that G418 actually increases the level of tTA expression in individual cells. The possibility that cells lose the tTA gene is less likely.
By modulating the amount of tetracycline in clonal human cell lines, we are able to quantitate the decline in levels of human TBP and TAF II 55 ( Figure  5 ). Although this method includes a summation of the decay rates of protein and mRNA, it provides a measure of the rate at which the levels of these transcription factors can be regulated. To our knowledge, this is the first description of the in vivo half-lives of basal transcription factors that are required for transcription of most eukaryotic genes by RNA polymerase II.
